You have access
Amelioration of Radiation Esophagitis by Orally Administered p53/Mdm2/Mdm4 Inhibitor (BEB55) or GS-Nitroxide
HYUN KIM, MARK E. BERNARD, MICHAEL W. EPPERLY, HONGMEI SHEN, ANDREW AMOSCATO, TRACY M. DIXON, ALEXANDER S. DOEMLING, SONG LI, XIANG GAO, PETER WIPF, HONG WANG, XICHEN ZHANG, VALERIAN E. KAGAN and JOEL S. GREENBERGER
In Vivo November 2011, 25 (6) 841-848;